Important COVID-19 guidelines
Please ensure you have read our latest statements on COVID-19 and RCR examinations before applying for or attending an examination. If you feel unwell or display symptoms you should not attend the examination. Social distancing rules and cleaning guidelines will be applied by each venue on an individual basis in line with government guidance and candidates should adhere to these.
February 2021 examination update
In light of the current situation, we have taken the decision to postpone the FRCR Part 1 and Final Part A examinations in Clinical Oncology planned to be held in February. We believe that planning to go ahead in February would be impractical and would pose far too much risk when the NHS is close to breaking point, and the situation is unlikely to improve for some weeks. The NHS is in a more difficult position than when we cancelled our FRCR examinations last spring. Whilst we have adapted the examination delivery, we could not justify going ahead in the face of the national emergency we currently encounter. We know that many trainees are being redeployed or having their training and preparation disrupted in other ways. The new examination date for the Final FRCR Part A examination in Clinical Oncology will be Thursday 29th April 2021.
The Final FRCR Part B examination in Clinical Oncology, which runs from 17th to 22nd April 2021, will now be before the Part A examination.
Priority 1 candidates (UK trainees and all NHS contributors) who applied for the Final FRCR Part A examination in Clinical Oncology in February 2021, that wish to attempt both Part A and Part B will now take the Final FRCR Part B examination first and continue to the Final FRCR Part A examination regardless of the outcome. Priority 2 Final Part A candidates will automatically be moved to April 29th, but will not be entered for the Final FRCR Part B April examination.
Due to the change of arrangements for the Final FRCR Part A examination, Priority 2 candidates are not permitted to apply for the April Final FRCR Part B examination.
A pass in the Final FRCR Part A examination will be valid for future attempts at the Final FRCR Part B examination, should they be needed. A candidate who passes the Final FRCR Part B examination but then fails the Final FRCR Part A examination would need to complete Part A examination at a future sitting for the award of FRCR and CCT, but would not need to repeat the Final FRCR Part B examination in Clinical Oncology.
We hope that this new timing will have minimal impact on trainee progression decisions as results will be available before most ARCPs take place. The curriculum derogations, adjusted decision aids and outcomes 10.1 and 10.2 as agreed last year will still apply at ARCPs.
Dual applications for the Final FRCR Part A and Part B examinations in Clinical Oncology (April 2021 sitting)
Please note the RCR examinations team will manually book any Priority 1 candidates who have applied for the Final FRCR Part A onto the Final FRCR Part B examination at the same venue where possible. This is a provisional booking with pending payment and candidates will receive an email by Friday 22 January. Please make payment through MyRCR upon receipt of this email.
Purpose of assessment
The Final FRCR (Part B) Examination expects candidates to have a wide knowledge of malignant disease and the management of patients with cancer. The main emphasis is on radiotherapy and drug therapy, but a good knowledge of general medicine, surgery and gynaecology is expected. Candidates are examined against the specialty training curriculum for clinical oncology and the clinical oncology syllabus. The Final FRCR Examination purpose of assessment statement details the examination's purpose, the required level of candidate training and the application of results. It is hoped that the statement will assist candidates, and those involved in their training, in understanding the scope of the FRCR examination and with relating the examination to other in-training assessments.
The Final FRCR (Part B) Examination comprises a clinical and an oral examination. Despite the change in clinical examination delivery, candidates’ revision for both components should remain the same. All responses given to examiners should reflect a non-COVID-19 environment.
- Candidates should review the RCR video depicting the virtual examination experience
- Please familiarise yourself with the guidance for using the virtual pen tool in Powerpoint and the sample oral outlining questions.
- A sample clinical viva question is also provided. (Please note this has not gone through the usual full peer review but is intended to give candidates an idea of content and style.) Short video clips may also form part of some clinical viva questions.
Dates and fees
How to apply
Applicants should ensure they have read the examination regulations before applying.
- Audio series: trainees share their experiences of the Final FRCR examination in clinical oncology
- The scoring system document explains how each component is marked and overall results are determined.
- Further general information on the examination is available in the candidate guidance notes.
- Sample oral questions for candidates.
- Instructions for candidates to follow during the clinical and oral examinations.
- Generic examiners' reports are available as a guide to candidates and trainers preparing for future sittings of the examination.